We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 3,047

New Legislation Aims to Assist HDHP Participants who have Chronic Conditions
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 14 2018

Last week the Chronic Disease Management Act of 2018 (the “Act”) was introduced in the House of Representatives. In its current form, the Act intends

Drug Costs Targeted in Administration’s Fiscal Year 2019 Budget
  • Cooley LLP
  • USA
  • February 13 2018

Yesterday, the Administration released its Fiscal Year 2019 (FY19) Budget blueprint. The $4.4 trillion Budget blueprint includes several proposals

FY 2019 President’s Budget - Health Care
  • Mintz Levin
  • USA
  • February 12 2018

Today, the White House released its FY 2019 budget proposal, outlining its policy priorities for the fiscal year. This is the first real budget of the

New law further supports cheaper prescription drugs
  • CMS
  • Belgium
  • January 31 2018

Parliament adopted a new law on 25 December 2017, which has as one of its objectives the promotion of the prescription of cheaper drugs. Prescription

Nieuwe wet moedigt kiezen voor goedkope geneesmiddelen verder aan
  • CMS
  • Belgium
  • January 31 2018

Op kerstdag 2017 heeft het parlement een nieuwe programmawet aangenomen. Eén van de doelstellingen ervan was het voorschrijven en de

Medicare Part D Cost Sharing Trends for Adult Vaccines
  • Manatt Phelps & Phillips LLP
  • USA
  • January 30 2018

Vaccination utilization among U.S. adults is low, and well below the Healthy People 2020 targets, despite widespread availability of safe and

Direct to Employer Contracting: Can It Improve Patient Engagement and Reduce Waste?
  • Pierce Atwood LLP
  • USA
  • January 29 2018

Since the enactment of both the Health Information Technology for Economic and Clinical Health Act (HITECH) and the Affordable Care Act (ACA), the

Drug Pricing May Return to HHS Agenda in 2018
  • Baker Donelson Bearman Caldwell & Berkowitz PC
  • USA
  • January 23 2018

Despite President Trump's pledge to rein in prescription drug pricing, the Administration did not take substantial action to address this issue in

New Jersey Clamps Down on Pharma Interactions with Prescribers
  • Arent Fox LLP
  • USA
  • January 22 2018

A new administrative rule promulgated and adopted by the Attorney General for the state of New Jersey (the AG) will “regulate the receipt and

Liability of Healthcare Providers in the Wake of Maryland’s Opioid Crisis
  • PK Law
  • USA
  • January 18 2018

When it comes to opioid use, the U.S. is in a league of its own. Roughly eighty percent of the world's opioid supply is consumed within the United